Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on LATAM Technology Reporter.
Press releases published on August 11, 2025
Gonzalo Araújo C and Criptolat to Take Center Stage at Fintech Summit Americas 2025 in Mexico City
CEO of SLM and founder of Criptolat, will join key executives from Binance, Bitso, Ibex, and Koywe at the Fintech Summit Americas 2025. MéXICO CITY, MEXICO, August 11, 2025 /EINPresswire.com/ -- Recognized as one of Latin America’s foremost technology …
New U.S. Politics Today Op-ed Says VOA Editorials Now Back Trump’s Political Agenda
WASHINGTON , DC, UNITED STATES, August 11, 2025 /EINPresswire.com/ -- For several decades, Voice of America has been a staple international multimedia broadcaster, known for promoting freedom and democracy in its reporting of news worldwide. But since …
Gonzalo Araújo C lleva la visión de SLM y Criptolat al Fintech Summit Americas 2025
El CEO de SLM y fundador de Criptolat participará en el Fintech Summit Americas 2025 para impulsar la integración de cripto y banca. CIUDAD DE MéXICO, MéXICO, MEXICO, August 11, 2025 /EINPresswire.com/ -- El empresario y tecnólogo Gonzalo Manuel Araújo …
HR Outsourcing PEO Agency Provides Ai Integrated Mental Health Employee Benefits
HR Outsourcing PEO Agency Provides Ai Integrated Mental Health Employee Benefits provide new frontier for Employee Benefits from PEO companies AUSTIN, TX, UNITED STATES, August 11, 2025 /EINPresswire.com/ -- Yuna Health, a leader in AI-powered mental …
Hire Heroes USA Receives $900,000 Grant from Scripps Family Impact Fund
Funding will expand career services for veterans and military spouses nationwide ALPHARETTA, GA, UNITED STATES, August 11, 2025 /EINPresswire.com/ -- Hire Heroes USA, a national nonprofit organization dedicated to empowering U.S. service members, …
John Kennedy FitzGerald Increases Ownership in Greenhawk Resources Inc. and Announces Leadership Changes
TORONTO, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Greenhawk Resources Inc. (“Greenhawk” or the "Company") (CSE: GRHK) announces John Kennedy FitzGerald (“FitzGerald”), of Toronto, Ontario announces that on Friday, August 8, 2025 he acquired in part through the …
Revive Therapeutics Announces Closing of First Tranche of Private Placement and Debt Settlement
TORONTO, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a specialty life sciences company dedicated to developing innovative therapeutics for critical medical needs, …
Swift Navigation and Taiwan Mobile Partner to Unlock Autonomy and Automation with Centimeter-Accurate Positioning
SAN FRANCISCO and TAIPEI, Taiwan, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Swift Navigation, the leader in centimeter-accurate positioning for vehicle autonomy, robotics, and precision logistics, and Taiwan Mobile, one of Taiwan’s leading telecommunications …
Critical One Announces $2.0 Million Non-Brokered Private Placement
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Critical One Energy Inc. (formerly Madison Metals Inc.) (“Critical One” or the “Company”) (CSE: CRTL) (OTCQB: MMTLF) (FSE: 4EF0) …
Microvast Reports Second Quarter 2025 Financial Results
Record Q2 revenue of $91.3 million, up 9.2% year over year Gross margin increased from 32.5% to 34.7%, a 2.2 percentage point improvement year over year STAFFORD, Texas, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Microvast Holdings, Inc. (NASDAQ:MVST) (“Microvast” …
Draganfly Announces Second Quarter Results of 2025 with 37% Increase in YoY Product Sales
Vancouver, BC., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8) (“Draganfly” or the “Company”), an award-winning, industry-leading drone solutions and systems developer, is pleased to announce its second quarter …
Nuvectis Pharma Announces the Initiation of the Phase 1b Program for NXP900
The Phase 1b program is designed to evaluate the clinical activity of NXP900 as a single agent in patients with advanced solid tumors whose cancers harbor specific genetic alterations, and in combination with EGFR and ALK inhibitors in patients with NSCLC …
Serina Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Highlights
HUNTSVILLE, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company advancing its lead IND candidate, SER-252, for advanced Parkinson's disease, enabled by its proprietary POZ …
BBOT Debuts as a Publicly Traded Company Focused on RAS-Pathway Malignances with a Potential to Realize the Full Promise of KRAS and PI3K Inhibition
Business combination transaction with Helix Acquisition Corp. II, a special purpose acquisition company sponsored by affiliates of Cormorant Asset Management, completed on August 11, 2025 Closed concurrent $261 million private investment in public equity …
Biofrontera Inc. Appoints George Jones as Chief Commercial Officer
Woburn, MA, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI) (the “Company”), a biopharmaceutical company focused on the development and commercialization of photodynamic therapy (PDT), today announced the appointment of George Jones as …
Microchip Technology to Present at the KeyBanc Technology Leadership Forum
CHANDLER, Ariz., Aug. 11, 2025 (GLOBE NEWSWIRE) -- (NASDAQ:MCHP) – Microchip Technology Incorporated, a leading provider of smart, connected, and secure embedded control solutions, today announced that the Company will present at the Mizuho 2025 Technology …
Longeveron Announces Closing Of Up To $17.5 Million Public Offering
MIAMI, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening, rare pediatric and chronic aging-related …
Tonix Pharmaceuticals Reports Second Quarter 2025 Financial Results and Operational Highlights
FDA PDUFA goal date of August 15, 2025, for TNX‑102 SL for fibromyalgia: if approved by FDA, TNX‑102 SL would be the first new drug for fibromyalgia in more than 16 years In June 2025, the Company was added to the Russell 3000® and Russell 2000® Indexes …
3D Systems Reports Second Quarter 2025 Financial Results
ROCK HILL, S.C., Aug. 11, 2025 (GLOBE NEWSWIRE) -- 3D Systems Corporation (NYSE:DDD) announced today its financial results for the second quarter ended June 30, 2025. Revenue of $95 million led by double-digit growth in Medical Technology and Aerospace …
Tempest Reports Second Quarter 2025 Financial Results and Provides Business Update
Received clearance to proceed with pivotal trial of amezalpat combination therapy for first-line hepatocellular carcinoma (HCC) in China Granted orphan drug designation from the European Medicines Agency (EMA) for amezalpat for the treatment of patients …